Multi-Cancer Early Detection (MCED) Blood Test
Providence Genomics now offers MCED testing, which can help detect cancer signals across 50 types of cancer from a single blood draw using innovative technology that has been extensively tested.
An MCED test represents cancer screening at a point in time and should be used in addition to standard, recommended cancer tests like mammogram and colonoscopy. It is intended to be repeated periodically for global cancer screening. If a cancer signal is detected, follow-up testing may include lab diagnostics or imaging.
At Providence, MCED tests cost about $700 for patients who receive genetic counseling. MCED testing isn’t currently covered by most insurance plans. Genetic counseling is often covered by insurance if patients meet the screening criteria, and some flexible spending plans may be applied toward the cost of counseling.
MCED testing may also be offered with other assessments. For some, it may follow a risk assessment and testing for inherited cancer risk. This approach provides a more comprehensive cancer screening plan. Typically, insurance covers testing for inherited cancer risk when it is medically indicated. However, many may proceed directly to MCED testing after an initial risk assessment.
Test Eligibility
MCED testing is recommended for use in adults with an elevated risk of cancer, such as those aged 50 and older with other risk factors including diabetes, smoking and certain viral exposures, or a family history of cancer.
More Information
For more information on Multi-Cancer Early Detection or to schedule your Galleri® MCED test, please call 855-306-2748 or complete the form.
MCED Cost and Coverage
At Providence, MCED tests cost about $700 for patients who receive genetic counseling. Most insurance plans don’t cover blood-based cancer screening tests, but some are beginning to offer coverage. Genetic counseling is often covered by insurance if patients meet the screening criteria, and some flexible spending plans may be applied toward the cost of counseling.
Important Safety Information
The MCED test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The MCED test doesn’t detect all cancers and should be used in addition to routine cancer screening tests recommended by a health care provider. The MCED test is intended to detect cancer signals, and some may predict where in the body the cancer signal is located.
For the best personalized care, results should be evaluated by a healthcare provider who will consider your medical history along with any clinical signs and symptoms you may have. This comprehensive approach ensures all factors are weighed for accurate and meaningful interpretation, enabling informed decision-making for you and your loved ones.
For more MCED test and safety information, please visit the Galleri® and Exact Sciences websites.